STATE STREET CORP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$231,993
-42.2%
161,1060.0%0.00%
Q2 2023$401,154
-24.5%
161,106
-18.7%
0.00%
Q1 2023$531,085
-72.8%
198,166
-44.9%
0.00%
Q4 2022$1,951,932
-90.3%
359,472
-77.8%
0.00%
-100.0%
Q3 2022$20,214,000
+2779.5%
1,618,381
+1038.1%
0.00%
Q2 2022$702,000
-97.5%
142,206
-96.1%
0.00%
-100.0%
Q1 2022$27,944,000
-36.4%
3,676,814
-14.5%
0.00%
-50.0%
Q4 2021$43,919,000
-25.3%
4,301,613
-1.9%
0.00%
-33.3%
Q3 2021$58,828,000
-3.2%
4,383,612
+58.2%
0.00%0.0%
Q2 2021$60,797,000
-7.5%
2,771,047
+1.5%
0.00%
-25.0%
Q1 2021$65,706,000
+41.6%
2,730,936
+5.9%
0.00%
+33.3%
Q4 2020$46,411,000
+69.9%
2,579,819
+9.1%
0.00%
+50.0%
Q3 2020$27,319,000
-17.3%
2,365,259
+73.8%
0.00%0.0%
Q2 2020$33,016,000
+118.3%
1,360,913
-0.9%
0.00%
+100.0%
Q1 2020$15,127,000
-58.4%
1,372,714
-0.2%
0.00%
-50.0%
Q4 2019$36,350,000
+39.0%
1,375,328
+19.8%
0.00%0.0%
Q3 2019$26,149,000
-36.2%
1,147,895
-14.1%
0.00%
-33.3%
Q2 2019$40,961,000
+105.2%
1,335,960
+11.1%
0.00%
+50.0%
Q1 2019$19,959,000
-14.0%
1,202,361
-0.8%
0.00%0.0%
Q4 2018$23,216,000
-45.8%
1,212,339
+47.9%
0.00%
-33.3%
Q3 2018$42,857,000
+4.5%
819,602
-13.1%
0.00%0.0%
Q2 2018$41,007,000
+398.8%
943,550
+325.2%
0.00%
+200.0%
Q1 2018$8,221,000
+254.5%
221,895
+89.9%
0.00%
Q4 2017$2,319,000
+96.0%
116,859
+145.4%
0.00%
Q3 2017$1,183,00047,6180.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders